| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Revenue | $20.3M | +5.0% |
| Cost of Revenue | $6.1M | -2.8% |
| Gross Profit | $14.2M | +8.8% |
| R&D Expense | $2.2M | +7.0% |
| SG&A Expense | $8.3M | +1.8% |
| Operating Income | $3.6M | +30.8% |
| Pre-tax Income | $4.6M | +34.8% |
| Income Tax | $965K | +224.9% |
| Net Income | $3.6M |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | -8.1% |
| Accounts Receivable | $3.5M | +32.2% |
| Inventory | $14.0M | +19.6% |
| Current Assets | $43.0M | +5.1% |
| Total Assets | $57.5M | +11.0% |
| Current Liabilities | $3.9M | +18.8% |
| Total Liabilities | $4.4M | +29.4% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.5M | +2.6% |
| Capital Expenditures | $503K | -75.1% |
| Investing Cash Flow | -$4.4M | -190.7% |
| Financing Cash Flow | -$16K | +13.0% |
| Free Cash Flow | $1.9M | +429.8% |
| +16.7% |
| EPS (Basic) | $0.33 | +17.9% |
| EPS (Diluted) | $0.32 | +14.3% |
| Stockholders' Equity |
| $53.1M |
| +9.7% |